Treatment of early stages of dialysis encephalopathy by aluminium depletion.
D000535:Aluminum / Q000009:adverse effects* / Q000378:metabolism; D001072:Apraxias / Q000139:chemically induced / Q000628:therapy; D001927:Brain Diseases / Q000139:chemically induced / Q000628:therapy*; D003676:Deferoxamine / Q000008:administration & dosage* / Q000378:metabolism; D004401:Dysarthria / Q000139:chemically induced / Q000628:therapy; D006801:Humans; D008297:Male; D006435:Renal Dialysis / Q000009:adverse effects*
D000535:Aluminum; D003676:Deferoxamine